Industry Webinars

From Our Industry Alliance Partners

Access great online learning content from SNMMI's Value Initiative Industry Partners:

• New! Real World Considerations for I-131 MIBG
  Nuclear medicine experts Dr. Erik Mittra, MD, PhD, and Adam Brown, BS, NMTCB, RT, provide a review of the clinical evidence surrounding the approval of HSA I-131-MIBG as well as best practices on patient preparation, execution of dosimetry and therapy, and monitoring and identification of adverse events.
• Hereditary Pheochromocytoma and Paraganglioma: Strategies for Screening and Surveillance
  Through discussions with a patient who is SDHB positive, Dr Lauren Fisbein will explain the significance of mutations and associated tumor risks.
• Targeted Therapeutics for Metastatic or Unresectable Pheochromocytoma and Paraganglioma
  Through discussions with a patient who has experienced malignant pheochromocytoma, Dr. Dan Pryma provides guidance on treatment options for metastatic disease. 

SNMMI 2022 Annual Meeting On-Demand Satellite Symposia

Hear directly from SNMMI's industry partners in these popular one-hour virtual presentations recorded at the 2022 Annual Meeting.
Note: CE Credit is not offered for these Satellite Symposia.

SNMMI 2021 Annual Meeting On-Demand Satellite Symposia

Hear directly from SNMMI's industry partners in these popular one-hour virtual presentations recorded at the 2021 Annual Meeting.
Note: CE Credit is not offered for these Satellite Symposia.